Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-15

Clinical Trial Update: Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Omidria and Dexycu or Omidria and Dextenza versus topical prednisolone acetate after cataract surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)
  • Dexycu (dexamethasone intraocular suspension)
  • Omidria (phenylephrine/ketorolac intraocular solution)
  • Prednisolone Acetate 1% (prednisolone acetate)

Snippet

Sponsor: Silverstein Eye Centers | Conditions: Cataract Surgery | Phase 4 | Status: COMPLETED